Barclays PLC Prokidney Corp Ord Shs Cl A(Cy Transaction History
Barclays PLC
- $377 Billion
- Q3 2024
A detailed history of Barclays PLC transactions in Prokidney Corp Ord Shs Cl A(Cy stock. As of the latest transaction made, Barclays PLC holds 146,321 shares of PROK stock, worth $228,260. This represents 0.0% of its overall portfolio holdings.
Number of Shares
146,321
Previous 146,321
-0.0%
Holding current value
$228,260
Previous $281,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding PROK
# of Institutions
79Shares Held
46.7MCall Options Held
505KPut Options Held
127K-
Morgan Stanley New York, NY14.3MShares$22.3 Million0.0% of portfolio
-
Suvretta Capital Management, LLC New York, NY12.3MShares$19.3 Million0.93% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.22MShares$8.14 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.66MShares$5.7 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.2MShares$3.44 Million0.0% of portfolio
About PROKIDNEY CORP ORD SHS CL A(CY
- Ticker PROK
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 61,540,200
- Market Cap $96M